PF-Atlas › Treatments › AI Knowledge Graph

AI Knowledge Graph

ML system connecting mechanisms across IPF, regeneration, aging, cancer fields

PF-Atlas model — Computational / preclinical hypothesis — not clinically validated. How PF-Atlas grades evidence.

Development stage

Available Now

Evidence level

Computational

Mechanism class

ML system connecting mechanisms across IPF, regeneration, aging, cancer fields

Timeline

12 months

Risk profile

Low

Developer

Insilico / Standigm / Multiple

Key researchers

Multiple

Overview

Standigm ASK knowledge graph identified novel IPF targets. Insilico AI discovered TNIK (validated in humans). Fastest path to finding untested drug combinations.

How AI Knowledge Graph fits into IPF treatment

AI Knowledge Graph is classified as Computational at the Available Now stage. Explore how it compares to other options and where it sits in the development pipeline:

AI Knowledge Graph drug profile ML system connecting mechanisms across IPF, regeneration, aging, cancer fields Clinical trials Drug pipeline Research

Other IPF treatments

Nerandomilast / Jascayd Inhaled Treprostinil / Tyvaso Admilparant / BMS-986278 Rentosertib / ISM001-055 uPAR-CAR-T Senolytic Immunotherapy Senolytics + WNT Agonist Combination

Medical disclaimer. This page summarizes published research and PF-Atlas model output about AI Knowledge Graph for information only. It is not medical advice or a treatment recommendation. Drug availability, approval status and evidence change — verify with a pulmonologist and official sources (FDA, ClinicalTrials.gov) before any decision.